Patrice Joseph

33 Harry Truman Boulevard
Port-au-prince, OU, Haiti

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 36 publications

Implementation of differentiated service delivery strategies for patients with tuberculosis in Haiti during a severe humanitarian crisis, January-August 2021.

Implementation of differentiated service delivery strategies for patients with tuberculosis in Haiti during a severe humanitarian crisis, January-August 2021.

Journal: PLOS global public health

Published: March 16, 2026

PEPFAR Investments in Country Data Systems Support HIV Treatment Continuity: An Example From Haiti.

PEPFAR Investments in Country Data Systems Support HIV Treatment Continuity: An Example From Haiti.

Journal: The Journal of infectious diseases

Published: September 21, 2025

Three-Year Outcomes After Programmatic Transitioning to Dolutegravir in the Context of Severe Civil Unrest in Haiti.

Three-Year Outcomes After Programmatic Transitioning to Dolutegravir in the Context of Severe Civil Unrest in Haiti.

Journal: Open forum infectious diseases

Published: February 12, 2025

Predictors of Clinical Outcomes Among People With Human Immunodeficiency Virus and Tuberculosis Symptoms After Rapid Treatment Initiation in Haiti.

Predictors of Clinical Outcomes Among People With Human Immunodeficiency Virus and Tuberculosis Symptoms After Rapid Treatment Initiation in Haiti.

Journal: Open forum infectious diseases

Published: September 23, 2024

Predictors of Clinical Outcomes among People with HIV and Tuberculosis Symptoms after Rapid Treatment Initiation in Haiti.

Predictors of Clinical Outcomes among People with HIV and Tuberculosis Symptoms after Rapid Treatment Initiation in Haiti.

Journal: medRxiv : the preprint server for health sciences

Published: July 01, 2024

Potential Utility of C-reactive Protein for Tuberculosis Risk Stratification Among Patients With Non-Meningitic Symptoms at HIV Diagnosis in Low- and Middle-income Countries.

Potential Utility of C-reactive Protein for Tuberculosis Risk Stratification Among Patients With Non-Meningitic Symptoms at HIV Diagnosis in Low- and Middle-income Countries.

Journal: Open forum infectious diseases

Published: April 01, 2024

Continuity of care during severe civil unrest with a model of community-based HIV care: a retrospective cohort study from Haiti.

Continuity of care during severe civil unrest with a model of community-based HIV care: a retrospective cohort study from Haiti.

Journal: Lancet regional health. Americas

Published: February 23, 2024

Potential Utility of C-reactive Protein for Tuberculosis Risk Stratification among Patients with Non-Meningitic Symptoms at HIV Diagnosis in Low- and Middle-Income Countries.

Potential Utility of C-reactive Protein for Tuberculosis Risk Stratification among Patients with Non-Meningitic Symptoms at HIV Diagnosis in Low- and Middle-Income Countries.

Journal: medRxiv : the preprint server for health sciences

Published: January 10, 2024

Successful outcomes for patients with drug-resistant tuberculosis despite civil unrest and COVID-19 in Haiti.

Successful outcomes for patients with drug-resistant tuberculosis despite civil unrest and COVID-19 in Haiti.

Journal: PLOS global public health

Published: January 19, 2023

Leveraging PEPFAR-Supported Health Information Systems for COVID-19 Pandemic Response.

Leveraging PEPFAR-Supported Health Information Systems for COVID-19 Pandemic Response.

Journal: Emerging infectious diseases

Published: December 11, 2022

Same-day testing with initiation of antiretroviral therapy or tuberculosis treatment versus standard care for persons presenting with tuberculosis symptoms at HIV diagnosis: A randomized open-label trial from Haiti.

Same-day testing with initiation of antiretroviral therapy or tuberculosis treatment versus standard care for persons presenting with tuberculosis symptoms at HIV diagnosis: A randomized open-label trial from Haiti.

Journal: PLoS medicine

Published: December 01, 2022

Time to Culture Conversion of Bedaquiline and High-Dose Isoniazid for Drug-Resistant Tuberculosis.

Time to Culture Conversion of Bedaquiline and High-Dose Isoniazid for Drug-Resistant Tuberculosis.

Journal: Open forum infectious diseases

Published: May 13, 2022

Showing 1-12 of 36

Last Updated: 09/26/2026